Dermatology Clinic

Advanced Basal Cell Carcinoma Clinic

Make an appointment


Director: Anne Chang, MD

Anthony E. Oro, MD, PhD
Jean Y. Tang, MD, PhD

Stanford’s Department of Dermatology provides pioneering and outstanding care for patients with advanced basal cell carcinoma, including locally advanced and metastatic basal cell carcinomas (BCCs). BCCs are the most common cancer in the Caucasian population and are curable when found early. However, a number of them are aggressive and recur after surgery or radiation therapy.

We accept referrals from around the world for individuals with BCCs that are not amenable to surgery due to their size, location, likelihood of unacceptable morbidity from surgery, or advanced stage. 

We work closely with medical oncology, radiation oncology, Moh’s surgery (in conjunction with Dr. Sumaira Aasi), plastic and reconstructive surgery, general surgery, and radiology at Stanford to provide the highest level of care to our patients.

Patients are seen in the Dermatology Clinic in the Stanford Medical Outpatient Center (SMOC) in Pavilion B, 4th floor.

Referrals:
Patient Line: 650-723-6316
Physician Line: 650-721-8211 OR dermatologynewpatients@stanfordmed.org
Clinical Trials: 650-721-7159 or 650-721-7151

Contacts:
Email: Maritess Sales, RN at msales@stanfordmed.org

Why is this clinic needed?

We are a resource for state-of-the-art treatments for basal cell skin cancers and provide consultations on the optimal treatment of advanced basal cell carcinomas

Access to Cutting Edge BCC Drugs: We have extensive experience with cutting edge drugs such as Smoothened Inhibitors, which are a targeted method of attacking basal cell skin cancers. We monitor closely for their side effects and minimize their impact on quality of life

Drug Resistance: Patients on BCC treatments such as Smoothened Inhibitors may develop resistance to the drugs. We help to monitor for drug resistance and work with our colleagues in other disciplines to access other modalities of treatment.

Detection of new skin cancers: Patients with one basal cell skin cancer are at risk for developing additional skin cancers. We provide regular and thorough skin examinations to detect new concerning lesions early, while they are easily treated.

Prevention of skin cancer: Patients with one basal cell skin cancer are at risk for developing additional skin cancers. We provide education on protection from sun exposure and other forms of ultraviolet radiation, as well as self-skin examination to detect concerning lesions early.

 

Stanford Medicine Resources:

Footer Links: